John A. Auchampach

ORCID: 0000-0002-8005-4599
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Adenosine and Purinergic Signaling
  • Cardiac Ischemia and Reperfusion
  • Receptor Mechanisms and Signaling
  • Pharmacological Receptor Mechanisms and Effects
  • Cardiac Arrest and Resuscitation
  • Cardiac electrophysiology and arrhythmias
  • Anesthesia and Neurotoxicity Research
  • Neuropeptides and Animal Physiology
  • RNA modifications and cancer
  • Mechanical Circulatory Support Devices
  • Congenital heart defects research
  • Ubiquitin and proteasome pathways
  • Cardiac Fibrosis and Remodeling
  • Peptidase Inhibition and Analysis
  • Nitric Oxide and Endothelin Effects
  • Signaling Pathways in Disease
  • Cannabis and Cannabinoid Research
  • Ion channel regulation and function
  • Neuroscience and Neuropharmacology Research
  • Transplantation: Methods and Outcomes
  • RNA Interference and Gene Delivery
  • Calcium signaling and nucleotide metabolism
  • Mitochondrial Function and Pathology
  • Synthesis and Biological Evaluation
  • RNA Research and Splicing

Medical College of Wisconsin
2015-2024

National Institute of Diabetes and Digestive and Kidney Diseases
2024

National Institutes of Health
2024

University of Padua
2024

University of Virginia
1996-2014

Versiti Blood Center of Wisconsin
2014

Williams & Associates
2007

United States Military Academy
2006

University of Louisville
1997-2002

University of Cincinnati
2002

Single or multiple brief periods of ischemia (preconditioning) have been shown to protect the myocardium from infarction after a subsequent more prolonged ischemic insult. To test hypothesis that preconditioning is result opening ATP-sensitive potassium (KATP) channels, selective KATP channel antagonist, glibenclamide, was administered before immediately in barbital-anesthetized open-chest dogs subjected 60 minutes left circumflex coronary artery (LCX) occlusion followed by 5 hours...

10.1161/01.res.70.2.223 article EN Circulation Research 1992-02-01

The plant-derived cannabinoids Δ 9 -tetrahydrocannabinol (THC) and cannabidiol (CBD) both have immunosuppressive effects; although some effects of THC are mediated by the CB 2 receptor, binds CBD weakly. In examining on microglial proliferation, we found that these compounds potently inhibit [ 3 H]thymidine incorporation into a murine cell line with no effect cycle. Treatment decreased uptake microglia, IC 50 values match inhibition DNA. and, less potently, H]adenosine to similar extent as...

10.1073/pnas.0511232103 article EN Proceedings of the National Academy of Sciences 2006-05-04

The objective of the present study was to characterize role adenosine in myocardial ischemic preconditioning canine heart. Preconditioning with 5 min ischemia resulted a marked reduction infarct size after 60 left circumflex coronary artery occlusion and h reperfusion barbital-anesthetized dogs compared that were not preconditioned (4.8 +/- 1.9 vs. 27.9 4.5%; P < 0.05). Pretreatment either nonselective receptor antagonist PD 115199 or selective A1 8-cyclopentyl-1,3-dipropylxanthine...

10.1152/ajpheart.1993.264.5.h1327 article EN AJP Heart and Circulatory Physiology 1993-05-01

Journal Article Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate Get access John A Auchampach, Auchampach Department Pharmacology and Toxicology, Medical College Wisconsin, 8701 Waterdown Plank Road, Milwaukee, WI 53226, USA: J G Gross; Bristol-Myers Squibb, Princeton, New Jersey, Grover. Correspondence to Dr Gross. Search for other works this author on: Oxford Academic PubMed Google Scholar Gary Grover, Grover...

10.1093/cvr/26.11.1054 article EN Cardiovascular Research 1992-11-01

Using conscious rabbits, we examined the effect of ischemic preconditioning (PC) on p44 and p42 mitogen-activated protein kinases (MAPKs). We found that both isoforms contribute significantly to total MAPK activity in heart (in-gel kinase assay: p44, 59 ± 1%; p42, 41 1%). Ischemic PC (6 cycles 4-min occlusion/4-min reperfusion) elicited a pronounced increase cellular (+89%). This increase, which occurred exclusively nuclear fraction, was contributed by +97%; +210%) accompanied migration two...

10.1152/ajpheart.1999.276.5.h1468 article EN AJP Heart and Circulatory Physiology 1999-05-01

We cloned and characterized the canine A<sub>3</sub> adenosine receptor (AR) examined AR-induced degranulation of BR line mastocytoma cells. Canine A<sub>3</sub>AR transcript is found predominantly in spleen, lung, liver, testes encodes a 314-amino acid heptahelical receptor.<sup>125</sup>I-<i>N</i><sup>6</sup>-Aminobenzyladenosine binds to two affinity states with<i>K</i><sub><i>D</i></sub> values 0.7 ± 0.1 16 0.8 nm, reflecting G protein-coupled -uncoupled receptors, respectively. Xanthine...

10.1124/mol.52.5.846 article EN Molecular Pharmacology 1997-11-01

Adenosine is elaborated in injured tissues where it suppresses inflammatory responses of essentially all immune cells, including production proinflammatory cytokines such as tumor necrosis factor-α (TNF-α). Most the anti-inflammatory actions adenosine have been attributed to signaling through A<sub>2A</sub> receptor (A<sub>2A</sub>AR). Previously, however, has shown that A<sub>3</sub>AR agonist <i>N</i><sup>6</sup>-(3-iodobenzyl)adenosine-5′-<i>N</i>-methylcarboxamide (IB-MECA) potently...

10.1124/jpet.105.096016 article EN Journal of Pharmacology and Experimental Therapeutics 2005-12-09

BACKGROUND Several recent studies suggest that activation of ATP-dependent potassium (K(ATP)) channels in the myocardium plays an important cardioprotective role during ischemia. The present study was undertaken to examine further this ion channel vivo a model "stunned" myocardium. METHODS AND RESULTS Barbital-anesthetized dogs were subjected 15 minutes left anterior descending (LAD) coronary artery occlusion followed by 3 hours reperfusion. Regional myocardial blood flow measured...

10.1161/01.cir.86.1.311 article EN Circulation 1992-07-01

Abstract To examine the cardioprotective role of A 3 adenosine receptors during myocardial ischemia/reperfusion injury, we tested effect N 6 -(3-iodobenzyl)adenosine-5′- -methyluronamide (IB-MECA), a potent and selective receptor agonist, in models stunning infarction chronically instrumented conscious rabbits. In phase I (studies stunning), rabbits were subjected to six 4-minute coronary occlusions, each separated by reperfusion periods, after which recovery systolic wall thickening was...

10.1161/01.res.80.6.800 article EN Circulation Research 1997-06-01

purpose. Cannabidiol (CBD), a nonpsychotropic, nontoxic compound has been shown to block diabetes- and endotoxin-induced retinal damage. However, the protective mechanism of this anti-inflammatory cannabinoid is not completely understood. The goal study determine role adenosine signaling in inflammation its potential modulation by CBD. methods. receptor (AR) subtypes expressed rat microglial cells were assessed quantitative real-time RT-PCR. AR function was determined via vitro vivo...

10.1167/iovs.08-2196 article EN Investigative Ophthalmology & Visual Science 2008-11-26

Inhibition of adenosine receptors could reduce metastasis by enhancing prenylation-dependent signaling that promotes cell-cell adhesion.

10.1126/scisignal.2003374 article EN Science Signaling 2013-05-28

(N)-Methanocarba adenosine 5'-methyluronamides containing known A(3) AR (adenosine receptor)-enhancing modifications, i.e., 2-(arylethynyl)adenine and N(6)-methyl or N(6)-(3-substituted-benzyl), were nanomolar full agonists of human (h) A(3)AR highly selective (K(i) ∼0.6 nM, 2-(halophenylethynyl) analogues 13 14). Combined 2-arylethynyl-N(6)-3-chlorobenzyl substitutions preserved affinity/selectivity in the (N)-methanocarba series (e.g., 3,4-difluoro agonist MRS5698 31, K(i) 3 mouse A(3))...

10.1021/jm300396n article EN Journal of Medicinal Chemistry 2012-05-04

Abstract —We investigated whether activation of A 1 or 3 adenosine receptors (ARs) induces late preconditioning (PC) against infarction in conscious rabbits using the selective AR agonists 2-chloro- N 6 -cyclopentyladenosine (CCPA) and -3-iodobenzyladenosine-5′- -methylcarboxamide (IB-MECA). In vitro radioligand binding cAMP assays demonstrated CCPA to be ≈200- 400-fold for rabbit IB-MECA ≈20-fold AR. We observed that (1) pretreatment 24 hours earlier with (100 μg/kg IV bolus) 300 μg/kg)...

10.1161/01.res.88.5.520 article EN Circulation Research 2001-03-16

The objective of the present study was to determine effect a novel K+ channel opener, Aprikalim (RP 52891; [trans-(-)-N-methyl-2-(3-pyridyl)-2-tetrahydrothio-pyran carbothiamide-1-oxide]), on myocardial infarct size in barbital-anesthetized dogs subjected 90 min left circumflex coronary artery occlusion followed by 5 hr reperfusion. To if RP 52891 is mediating its effects opening adenosine triphosphate regulated potassium channels (KATP), glibenclamide, KATP antagonist used. Dogs were...

10.1016/s0022-3565(25)20572-9 article EN Journal of Pharmacology and Experimental Therapeutics 1991-12-01

The objective of this study was to determine whether ATP-dependent potassium channel activation is involved in the mechanism by which nicorandil reduces postischemic contractile dysfunction produced a brief period ischemia (myocardial stunning). Barbital-anesthetized dogs were subjected 15-min left anterior descending (LAD) coronary artery occlusion followed 3-h reperfusion. Saline or (100 micrograms/kg + 25 micrograms/kg/min) infused 15 min before and throughout with without addition KATP...

10.1097/00005344-199205000-00012 article EN other-oa Journal of Cardiovascular Pharmacology 1992-05-01

We used pharmacological agents and genetic methods to determine whether the potent A<sub>3</sub> adenosine receptor (AR) agonist 2-chloro-<i>N</i><sup>6</sup>-(3-iodobenzyl)adenosine-5′-<i>N</i>-methylcarboxamide (Cl-IB-MECA) protects against myocardial ischemia/reperfusion injury in mice via A<sub>3</sub>AR or interactions with other AR subtypes. Pretreating wild-type (WT) Cl-IB-MECA reduced infarct size induced by 30 min of coronary occlusion 24 h reperfusion at doses (30 100 μg/kg) that...

10.1124/jpet.106.111351 article EN Journal of Pharmacology and Experimental Therapeutics 2006-09-19

The role of endothelial nitric oxide synthase (eNOS) in isoflurane postconditioning (IsoPC)-elicited cardioprotection is poorly understood. authors addressed this issue using eNOS mice.In vivo or Langendorff-perfused mouse hearts underwent 30 min ischemia followed by 2 h reperfusion the presence and absence produced with 5 before 3 after reperfusion. Ca+-induced mitochondrial permeability transition (MPT) pore opening was assessed isolated mitochondria. Echocardiography used to evaluate...

10.1097/aln.0b013e3181c4a607 article EN Anesthesiology 2009-12-17

We examined the cardioprotective profile of new A<sub>3</sub> adenosine receptor (AR) agonist CP-532,903 [<i>N</i><sup>6</sup>-(2,5-dichlorobenzyl)-3′-aminoadenosine-5′-<i>N</i>-methylcarboxamide] in an vivo mouse model infarction and isolated heart global ischemia/reperfusion injury. In radioligand binding cAMP accumulation assays using human embryonic kidney 293 cells expressing recombinant ARs, was found to bind with high affinity A<sub>3</sub>ARs (<i>K</i><sub>i</sub> = 9.0 ± 2.5 nM)...

10.1124/jpet.107.127480 article EN Journal of Pharmacology and Experimental Therapeutics 2007-09-28

This study describes the localization and computational prediction of a binding site for A<sub>3</sub> adenosine receptor (A<sub>3</sub>AR) positive allosteric modulator 2-cyclohexyl-1<i>H</i>-imidazo[4,5-c]quinolin-4-(3,4-dichlorophenyl)amine (LUF6000). The work reveals an extrahelical lipid-facing pocket disparate from orthosteric that encompasses transmembrane domain (TMD) 1, TMD7, Helix (H) 8, which was predicted by molecular modeling validated mutagenesis. According to model, nearly...

10.1124/molpharm.123.000784 article EN Molecular Pharmacology 2024-01-05

The effects of nicorandil, a nicotinamide nitrate with K+-channel-opening activity, was investigated in several models ischemia-reperfusion injury conscious and anesthetized dogs or isolated buffer-perfused rat hearts. In reversible ischemic (stunned myocardium) dogs, nicorandil resulted an enhanced recovery regional systolic shortening during reperfusion after single episode coronary artery occlusion (10–15 min). These beneficial actions were not shared by the nitrovasodilator sodium...

10.1097/00005344-199206203-00006 article EN Journal of Cardiovascular Pharmacology 1992-01-01
Coming Soon ...